[Physiopathology, clinical aspects and therapy of shock in meningococcic sepsis].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001002:Anuria / Q000209:etiology; D001778:Blood Coagulation Disorders / Q000209:etiology; D006439:Hemodynamics; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008589:Meningococcal Infections / Q000150:complications*; D010952:Plasma Substitutes / Q000627:therapeutic use; D012121:Respiration, Artificial; D012772:Shock, Septic / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D013566:Sympathomimetics / Q000627:therapeutic use; D014662:Vasoconstrictor Agents / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use; D014882:Water-Electrolyte Balance
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D000933:Antifibrinolytic Agents; D010952:Plasma Substitutes; D013566:Sympathomimetics; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D006493:Heparin
Fisiopatologia, clinica e terapia dello shock in corso di sepsi meningococcica